News

A new study from experts within EACS analyses the first ~100 reported cases of virological failure with long-acting cabotegravir/rilpivirine (CAB/RPV-LA).

The key takeaway: failure remains rare, but when it occurs it is often associated with emergent resistance, sometimes affecting future treatment options. RPV or CAB levels at failure were often low; however, similar low levels are sometimes also observed in successfully treated individuals, highlighting the complexity of interpreting drug concentrations.

As long-acting antiretroviral therapies become more widely used, continued monitoring of resistance patterns and viral subtypes will be critical.

Congratulations to the authors Maria Mazzitelli, Milosz Parczewski, David Burger, and Annemarie Wensing for this important contribution.

Published in Clinical Infectious Diseases

https://bit.ly/VirologicalFailure  

https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciag046/8508656?login=false

International Women's Day is an important occasion to highlight women’s health and to recognise the specific needs of women living with or vulnerable to HIV. WAVE continues to bring attention to these issues by supporting research, sharing expertise and working with clinical and community partners across Europe.

To mark this day, Nina Weis, Chair of WAVE, has written an editorial in HIV Medicine. Her piece outlines current priorities in women’s health, including the challenges faced by women who are migrants, the need for clearer guidance on menopause in women with HIV, ongoing gaps in HPV screening, and the importance of improving healthcare experiences for women across Europe. The editorial also reflects on recent work in breastfeeding guidance and continued activities of the WAVE in Ukraine workshop.

Article available here. 

Under the umbrella of the EACS Medical Exchange Programme, SCEP aims at promoting clinical, research and educational links between centres across Europe and facilitating exchange of models of clinical care in HIV medicine and allied specialities.

Fellows will have the opportunity to visit an EACS Clinical/Research Excellence Centre (CREC) specialised in HIV medicine for a period of 2 to 4 weeks. The CREC can also nominate a member of its team for a reciprocal visit for the same period of time and with the same financial rules.

Visit our website for more information on the application process, the eligibility criteria and the list of Clinical/Research Excellence Centres that can be visited.

Applications are open until 26 April 2026.

The HIV Advanced Training Forum is a two-day international course organised on 25-26 March 2026 in Bucharest Romania, through the collaboration of leading academic and clinical institutions across Europe. 

The course is designed to equip early-career healthcare professionals with practical, patient-centered strategies for long-term HIV care.

Learn more and register.

ID and HIV Dialogues 2026 is a leading event organised in Bucharest Romania on 26-28 March 2026, dedicated to excellence in HIV and infectious diseases. Currently at its seventh edition, the conference brings together distinguished European experts and major scientific societies to deliver state-of-the-art updates in HIV prevention and treatment, viral hepatitis, antimicrobial resistance, emerging infections, diagnostics, and vaccination.

​

With high-level keynote lectures, interactive sessions, and strategic dialogue at the intersection of science, clinical practice, and public health, ID and HIV Dialogues stands as a landmark event shaping the future of infectious disease medicine in Romania and beyond.

​

More information here

Penta has launched PentaTr@ining 2026, a programme designed for healthcare professionals managing paediatric HIV and other congenital infections. The course provides updated, scientifically rigorous training on the latest treatment guidelines and management strategies for infants, children, and adolescents.

​

The programme offers two flexible components that can be taken together for a full certification or as individual training:

​

Online e-Learning: Starting 20 April 2026, this interactive phase includes six case-based modules and live webinars covering topics from vertical transmission to complex co-infections.

​

Residential Workshop: Taking place 15–17 September 2026 at the University of Padua, Italy, this three-day in-person event focuses on high-level clinical case discussions and expert-led networking.

​

Registration is now open, with tiered fees available for various professional backgrounds and regions.

More information.

Register here.

Following the 20th EACS Conference in Paris in 2025, members of the EACS Young Investigator Network (YING) collaborated to write a summary article highlighting the most important findings from the conference. 

The article covers key developments in antiretroviral therapy, comorbidities, women and children, PrEP, HIV prevention, testing and migration, STIs and STI prevention, HIV cure, and molecular epidemiology. 

The full article is now published in HIV Medicine (accessible via subscription or institution access).

Article available here

You can still apply for the YING Conference 2026! The Conference will take place on 5-6 June 2026, in Valencia, Spain.
 
This two-day event brings together a new generation of HIV experts from the WHO European Region, offering a fresh perspective and an innovative approach to HIV across Europe. The YING Conference addresses hot topics in the field of HIV through plenary sessions and interactive workshops. 

Applications are open until 15 February 2026.

EACS will cover travel and accommodation in Valencia for all selected participants for 2 nights (arrival on 04/06 and departure on 6/06).

Click here for more information and the preliminary programme.